Literature DB >> 14570373

Liberalization of donor criteria in lung transplantation.

David Whiting1, Anamika Banerji, David Ross, Michael Levine, Robert Shpiner, Stephanie Lackey, Abbas Ardehali.   

Abstract

Donor shortage remains a major obstacle to widespread application of lung transplantation. In region 5, including California, Nevada, New Mexico, Utah, and Arizona, the United Network of Organ Sharing (UNOS) database median waiting time for lung transplant candidates in 2000-2001 exceeded 17 months. The purpose of this study was to determine the impact of liberalization of donor criteria on median waiting time and short-term outcome of lung transplantation. From September 1999 to October 2002, 42 patients underwent lung transplantation from nonstandard donors. The donors were classified as nonstandard due to (1) infiltrate on chest radiograph (n = 33), (2) PaO2 < 300 on FiO2 1.0 and PEEP 5 (n = 3), (3) PaO2 < 100 on FiO2 0.4 and PEEP 5 (n = 3), (4) purulent sputum on bronchoscopy (n = 22), and (5) smoking history greater than 50 pack-years (n = 1). Perioperative characteristics and short-term outcome of this group was analyzed. The median waiting time for this cohort was 114 days (range, 10-1267), as compared with the national UNOS database median waiting time of 24 months between 1996 and 2001. The incidence of ischemia reperfusion injury was 2.3 per cent. None of the recipients developed pneumonia. The median ventilator support time was 2 days (range, 1-95). The median ICU stay and hospital stay were 4 days (range, 2-103) and 14 days (range, 5-194), respectively. The 3-month survival was 97.6 per cent. Selective liberalization of donor lung criteria can decrease the waiting time and is associated with favorable short-term outcome. Utilization of nonstandard lungs can expand the donor pool.

Entities:  

Mesh:

Year:  2003        PMID: 14570373

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  5 in total

Review 1.  Lung donor selection criteria.

Authors:  John Chaney; Yoshikazu Suzuki; Edward Cantu; Victor van Berkel
Journal:  J Thorac Dis       Date:  2014-08       Impact factor: 2.895

2.  Advancing donor management research: design and implementation of a large, randomized, placebo-controlled trial.

Authors:  Lorraine B Ware; Tatsuki Koyama; Dean Billheimer; Megan Landeck; Elizabeth Johnson; Sandra Brady; Gordon R Bernard; Michael A Matthay
Journal:  Ann Intensive Care       Date:  2011-06-14       Impact factor: 6.925

3.  Coronary revascularization in lung transplant recipients with concomitant coronary artery disease.

Authors:  A W Castleberry; J T Martin; A A Osho; M G Hartwig; Z A Hashmi; G Zanotti; L K Shaw; J B Williams; S S Lin; R D Davis
Journal:  Am J Transplant       Date:  2013-09-18       Impact factor: 8.086

4.  Donor age and early graft failure after lung transplantation: a cohort study.

Authors:  M R Baldwin; E R Peterson; I Easthausen; I Quintanilla; E Colago; J R Sonett; F D'Ovidio; J Costa; J M Diamond; J D Christie; S M Arcasoy; D J Lederer
Journal:  Am J Transplant       Date:  2013-08-26       Impact factor: 8.086

5.  The outcomes of 80 lung transplants in a single center from Saudi Arabia.

Authors:  Saeed Akram; Imran Yaqoob Nizami; Mohamed Hussein; Waleed Saleh; Mohammed Said Ismail; Khaled AlKattan; Muhammad Shaheryar Ahmed Rajput
Journal:  Ann Saudi Med       Date:  2019-08-05       Impact factor: 1.526

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.